在白血病中基于aptamer的方法:针对性治疗中的范式转变
Alireza Bayani1, Munthar Kadhim Abosaoda2,3,4, Jasur Rizaev5
1Division of Laboratory Hematology and Blood Banking, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Clinical and experimental medicine
|May 30, 2025
概括
合成的DNA和RNA分子,称为阿普坦,在诊断和治疗白血病方面表现有前途. 这些具有成本效益,灵敏和精确的工具为瘤学提供了个性化医学的新希望.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 胺是合成的单链DNA或RNA分子.
- 它们作为具有高特异性的化学抗体起作用.
- 亚胺正在成为癌症诊断和治疗的关键工具,尤其是白血病.
研究的目的:
- 审查针对白血病的基于aptamer的技术的最新进展.
- 突出阿普坦在个性化医学和瘤学的潜力.
- 讨论阿帕特默的临床应用中的挑战和障碍.
主要方法:
- 关于在白血病中应用阿巴特默的最新科学文献的综述.
- 基于aptamer的诊断和治疗策略的分析.
- 探索生物标志物和药物递送增强的aptamer向.
主要成果:
- 适配器具有高的成本效益,灵敏度和精度.
- 它们使得异常生物标志物的特定向和信号通路的调制成为可能.
- 胺增强药物递送效率,优化治疗结果.
- 有潜力改进预后模型并改善最小残留疾病监测.
结论:
- 亚胺为改变白血病诊断和治疗提供了显著的潜力.
- 它们在推进瘤学的个性化医疗方法方面起着关键作用.
- 需要进一步的研究来克服全面临床整合的挑战.
更多相关视频
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
4.3K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
1.3K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
